INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

24,511 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$697K
3,500 sh
Oct 15, 2026Oct 19, 2026
Page 69 of 613
← PrevNext →
traded Oct 15, 2026
+4d
SEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$470K
2,400 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

29
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$535K
2,700 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

28
Jonathan L. JacksonDJoint
GHGuardant Health, Inc.
Purchase
BUY$15K – $50KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHouse PTR

Evidence

28
RV
Radakovich Lynn VojvodichDirector
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
3,500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

27
AJ
Aballi JohnDirector, President and CEO
XGNEXAGEN INC.
Open-market sale
SELL$270K
34.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

26
KP
Kirol Charles PeterChief Operating Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale
SELL$154K
28.8K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

26
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$177K
900 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

26
JD
Jedda DanCFO & COO
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.07M
7,000 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

26
Jonathan L. JacksonDJoint
VSATVIASAT INC
Sale
SELL$50K – $100KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHouse PTR

Evidence

26
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$116K
600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

25
RS
Rajasekar SunilEVP Chief Prod & Strat Officer
HQYHEALTHEQUITY, INC.
Open-market purchase
BUY$9,756
108 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

25
BL
Borck LeonDirector
EQBKEQUITY BANCSHARES INC
Open-market purchase
BUY$19K
380 sh
Oct 19, 2026Oct 19, 2026
traded Oct 19, 2026
+0dSEC Form 4

Evidence

25
MR
McCrystle Kevin RossDirector, CEO
GRSDGRANDSTAND Ltd
Open-market purchase
BUY$3,365
2,901 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

24
Jonathan L. JacksonDSpouse
TYGTORTOISE ENERGY INFRASTRUCTURE CORP
Sale
SELL$1,001 – $15KSep 4, 2026Oct 19, 2026
traded Sep 4, 2026
+45dHouse PTR

Evidence

23
MD
Moore Alexander D.Director
PLTRPalantir Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$20K
100 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

23
HA
How AntoinetteChief Accounting Officer
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
20.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

22
TA
Toy AndrewDirector, Chief Executive Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$291K
62.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
DL
Dean LiaPres, Banking & Prem. Products
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$370K
1,887 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

21
KC
Karam CeliaPres, Retail Bank
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$377K
1,927 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

20
Michael A. RulliRSelf
WSBCWESBANCO INC
Sale
SELL$1,001 – $15KOct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dHouse PTR

Evidence

20
TC
Thornton Joseph ClayInterim CFO
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$21K
4,591 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

19
SK
Soares KarenChief Legal Officer
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$69K
14.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

19
GB
Gage BrodieEVP & Chief Product & Tech
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$413K
1,200 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

19
KM
Kumar MukulPRESIDENT, ENGINEERING
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$91K
5,400 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

19
WC
Wai ConradCEO, Counterpart Health
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$111K
23.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

18
SS
Schwartz SophiaChief Legal Officer, Secretary
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
48.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

17
LW
Lozinski Jeffrey William10% Owner
KSEZKinetic Seas Inc.
Open-market sale
SELL$2,838
114.9K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

16
KM
Kumar MukulPRESIDENT, ENGINEERING
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
2,600 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

16
DD
DiPerna DinoEVP & Chief R&D Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$156K
445 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

16
DD
DiPerna DinoEVP & Chief R&D Officer
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$153K
445 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

16
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$86K
18.3K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

15
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$16.81M
1.25M sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

15
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$15.61M
1.20M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

14
OH
Oey Peter HenryChief Financial Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$149K
50.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

14
BA
Ballotti Geoffrey ADirector, President and CEO
WHWYNDHAM HOTELS & RESORTS, INC.
Open-market sale · 10b5-1 plan
SELL$1.01M
13.7K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

14
KJ
Kandal Philipp Wolfgang JosefChief Product Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$90K
30.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

13
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$35K
3,000 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

11
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6.78M
128.1K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

11
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.02M
37.3K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence